Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amylin, Takeda Suspend Clinical Activities in Obesity Trial
Amylin, Takeda Suspend Clinical Activities in Obesity Trial
Amylin, Takeda Suspend Clinical Activities in Obesity Trial
Submitted by
admin
on March 16, 2011 - 11:59am
Source:
Bloomberg
News Tags:
obesity
Amylin
Takeda
pramlintide
metreleptin
Headline:
Amylin, Takeda Suspend Clinical Activities in Obesity Trial
Do Not Allow Advertisers to Use My Personal information
